Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Total Debt: 2017-2021

Historic Total Debt for Sunshine Biopharma (SBFM) over the last 4 years, with Dec 2021 value amounting to $1.9 million.

  • Sunshine Biopharma's Total Debt rose 100.21% to $1.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was $7.2 million, marking a year-over-year increase of 663.49%. This contributed to the annual value of $1.9 million for FY2021, which is 100.21% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Total Debt of $1.9 million as of FY2021, which was up 100.21% from $949,006 recorded in FY2020.
  • Over the past 5 years, Sunshine Biopharma's Total Debt peaked at $1.9 million during FY2021, and registered a low of $79,710 during FY2017.
  • Over the past 2 years, Sunshine Biopharma's median Total Debt value was $1.4 million (recorded in 2020), while the average stood at $1.4 million.
  • Data for Sunshine Biopharma's Total Debt shows a peak YoY spiked of 289.81% (in 2018) over the last 5 years.
  • Sunshine Biopharma's Total Debt (Yearly) stood at $79,710 in 2017, then soared by 289.81% to $310,718 in 2018, then reached $949,006 in 2020, then soared by 100.21% to $1.9 million in 2021.